344 related articles for article (PubMed ID: 20553528)
1. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.
James EA; DeVoti JA; Rosenthal DW; Hatam LJ; Steinberg BM; Abramson AL; Kwok WW; Bonagura VR
J Immunol; 2011 Jun; 186(11):6633-40. PubMed ID: 21531896
[TBL] [Abstract][Full Text] [Related]
3. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
4. Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).
Israr M; DeVoti JA; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Front Immunol; 2020; 11():336. PubMed ID: 32210959
[TBL] [Abstract][Full Text] [Related]
5. Recurrent laryngeal papillomatosis with oesophageal involvement in a 2 year old boy: successful treatment with the quadrivalent human papillomatosis vaccine.
Mészner Z; Jankovics I; Nagy A; Gerlinger I; Katona G
Int J Pediatr Otorhinolaryngol; 2015 Feb; 79(2):262-6. PubMed ID: 25496821
[TBL] [Abstract][Full Text] [Related]
6. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
7. Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.
DeVoti J; Hatam L; Lucs A; Afzal A; Abramson A; Steinberg B; Bonagura V
Mol Med; 2014 Aug; 20(1):372-80. PubMed ID: 24950037
[TBL] [Abstract][Full Text] [Related]
8. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
[TBL] [Abstract][Full Text] [Related]
9. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.
DeVoti JA; Rosenthal DW; Wu R; Abramson AL; Steinberg BM; Bonagura VR
Mol Med; 2008; 14(9-10):608-17. PubMed ID: 18607510
[TBL] [Abstract][Full Text] [Related]
11. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
12. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination.
Freed GL; Derkay CS
Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1799-803. PubMed ID: 16884786
[TBL] [Abstract][Full Text] [Related]
13. A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma.
Shah KV
J Infect Dis; 2014 May; 209(9):1307-9. PubMed ID: 24265442
[TBL] [Abstract][Full Text] [Related]
14. High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions.
Chong KT; Xiang L; Wang X; Jun EL; Xi LF; Schweinfurth JM
Virol J; 2006 Sep; 3():75. PubMed ID: 16961924
[TBL] [Abstract][Full Text] [Related]
15. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
Pan XF; Wang J; Xiao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
[TBL] [Abstract][Full Text] [Related]
16. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.
Gelder CM; Williams OM; Hart KW; Wall S; Williams G; Ingrams D; Bull P; Bunce M; Welsh K; Marshall SE; Borysiewicz L
J Virol; 2003 Feb; 77(3):1927-39. PubMed ID: 12525627
[TBL] [Abstract][Full Text] [Related]
17. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
[TBL] [Abstract][Full Text] [Related]
18. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
19. Enhanced T
Xiao Y; Wu X; Ma L; Gui J; Bai L; Ni X; Wang J
Immunol Lett; 2017 Nov; 191():31-34. PubMed ID: 28860041
[TBL] [Abstract][Full Text] [Related]
20. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
